Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?

about

Infusion hemolysis after pediatric major ABO-mismatched bone marrow transplant: Comparison of two red blood cell depletion techniques.ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation.

P2860

Q48344687-CE50879A-BBD5-4D83-8DB5-A57CEEEE120E Q50225112-29A696FE-1221-4317-8E52-0505F8D8F709

P2860

Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?

Item

http://www.wikidata.org/entity/Q40756603

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Is ABO mismatch another risk f ...... ediatric thalassemic patients?

@en

type

Item

label

Is ABO mismatch another risk f ...... ediatric thalassemic patients?

@en

prefLabel

Is ABO mismatch another risk f ...... ediatric thalassemic patients?

@en

P1476

Is ABO mismatch another risk f ...... ediatric thalassemic patients?

@en

P2093

Arzu Akcay

http://www.w3.org/2001/XMLSchema#string

Fatih Erbey

http://www.w3.org/2001/XMLSchema#string

Gulyuz Ozturk

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.

The cure of thalassemia by bone marrow transplantation.

Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.

ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.

Advances in the allogeneic transplantation for thalassemia.

Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine.

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin.

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.

Bone marrow transplantation in patients with thalassemia.

Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.

P304

645-651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PETR.12552

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Didem Atay

P577

2015-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279990587

http://www.w3.org/2001/XMLSchema#string

P698

26156679

http://www.w3.org/2001/XMLSchema#string

Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?

about

P2860

P2860

Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698